Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ResMed Denmark A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   0.5% 0.9% 0.5% 0.5% 0.6% 0.6% 9.4% 8.0%   Credit score (0-100)   99 90 98 99 97 98 25 31   Credit rating   AA A AA AAA AA AA BB BB   Credit limit (kDKK)   2,052.5 1,305.1 2,310.1 3,162.4 3,191.2 4,106.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   16,496 12,524 13,914 15,492 18,230 21,978 0.0 0.0   EBITDA   5,438 1,690 3,460 4,481 4,999 7,402 0.0 0.0   EBIT   5,174 1,483 3,396 4,441 4,977 7,393 0.0 0.0   Pre-tax profit (PTP)   5,123.2 1,443.0 3,358.4 4,373.1 4,893.0 7,460.6 0.0 0.0   Net earnings   3,935.6 1,124.3 2,617.1 3,404.4 3,812.6 5,817.7 0.0 0.0   Pre-tax profit without non-rec. items   5,123 1,443 3,358 4,373 4,893 7,461 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   267 121 73.9 34.2 12.5 75.5 0.0 0.0   Shareholders equity total   11,703 12,827 15,444 18,849 22,661 28,479 27,923 27,923   Interest-bearing liabilities   0.0 0.0 4,509 10,428 11,928 6,532 0.0 0.0   Balance sheet total (assets)   19,791 23,396 24,548 36,085 41,018 45,276 27,923 27,923   Net Debt   -7,125 -4,382 -3,226 -5,583 3,237 -5,366 -27,923 -27,923     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   16,496 12,524 13,914 15,492 18,230 21,978 0.0 0.0   Gross profit growth   -0.4% -24.1% 11.1% 11.3% 17.7% 20.6% -100.0% 0.0%   Employees   18 16 16 16 18 19 0 0   Employee growth %   0.0% -11.1% 0.0% 0.0% 12.5% 5.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,791 23,396 24,548 36,085 41,018 45,276 27,923 27,923   Balance sheet change%   -5.6% 18.2% 4.9% 47.0% 13.7% 10.4% -38.3% 0.0%   Added value   5,437.9 1,689.5 3,459.5 4,480.8 5,017.1 7,402.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -391 -352 -110 -79 -43 54 -75 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   31.4% 11.8% 24.4% 28.7% 27.3% 33.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.4% 6.9% 14.2% 14.6% 12.9% 17.3% 0.0% 0.0%   ROI %   41.4% 11.5% 19.2% 16.7% 14.9% 20.5% 0.0% 0.0%   ROE %   32.2% 9.2% 18.5% 19.9% 18.4% 22.8% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   59.1% 54.8% 62.9% 52.2% 55.2% 62.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -131.0% -259.3% -93.3% -124.6% 64.8% -72.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 29.2% 55.3% 52.6% 22.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 1.7% 0.9% 0.8% 0.2% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   2.0 2.0 2.7 1.9 2.0 2.7 0.0 0.0   Current Ratio   2.5 2.3 3.2 2.3 2.4 3.4 0.0 0.0   Cash and cash equivalent   7,124.7 4,381.5 7,735.0 16,010.2 8,690.5 11,898.3 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   11,381.4 12,636.5 16,068.8 19,637.4 23,529.4 30,634.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   302 106 216 280 279 390 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   302 106 216 280 278 390 0 0   EBIT / employee   287 93 212 278 277 389 0 0   Net earnings / employee   219 70 164 213 212 306 0 0